Cardiometabolic Role of Visfatin in Patients on Peritoneal Dialysis

Akarsu O., Baysal O., Karadag S., Gursu M., Ozkan O., Uzun S., ...More

TURKISH JOURNAL OF NEPHROLOGY, vol.29, no.4, pp.297-303, 2020 (ESCI) identifier identifier

  • Publication Type: Article / Article
  • Volume: 29 Issue: 4
  • Publication Date: 2020
  • Doi Number: 10.5152/turkjnephrol.2020.4123
  • Journal Name: TURKISH JOURNAL OF NEPHROLOGY
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.297-303
  • Bezmialem Vakıf University Affiliated: Yes

Abstract

Objective: There is a relationship between inflammation and cardiovascular disease (CVD) in patients with chronic kidney disease. Visfatin is an adipocytokine, which has been shown to be associated with inflammation, endothelial dysfunction, and CVD. Our study aimed to examine the relationship of visfatin with metabolic and echocardiographic parameters in patients on peritoneal dialysis (PD).